Abstract
No cases of tenofovir alafenamide (TAF)-induced alopecia have been reported in the literature. We describe 6 cases of hair loss in African American female patients after switching to TAF and aim to raise awareness about this potential adverse effect of TAF, which could predominate in certain patient populations.
Author supplied keywords
Cite
CITATION STYLE
APA
El Zein, S., Tabaja, H., Kanj, A., Richmond, D., & Veltman, J. (2019). Alopecia after Switch to Tenofovir Alafenamide in 6 African American Women. Open Forum Infectious Diseases, 6(7). https://doi.org/10.1093/ofid/ofz278
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free